secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sanara MedTech Inc. (SMTI)
CIK:        0000714256
Form:       8-K
Filed at:   2025-11-12T23:59:59+00:00
Accession:  0001493152-25-021615
Event type: other_material
Sentiment:  positive
Materiality: 0.60
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sanara MedTech discontinues Tissue Health Plus, reallocates resources to surgical business
--------------------------------------------------------------------------------

- Completed evaluation of strategic alternatives for THP; ceased development in late September and will discontinue operations.
- THP segment will be classified as discontinued operations; wind-down expected through end of 2025.
- Total cash investment in THP expected $5.5M to $6.5M in H2 2025; no material cash expenses after year-end.
- Management believes surgical business has greatest potential for sustainable long-term growth and value.
- Further details to be discussed on Q3 2025 earnings call scheduled for November 12, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/714256/000149315225021615/0001493152-25-021615-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/714256/000149315225021615/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-021615

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer